Something Exciting is Coming

We're working hard to bring you an amazing new experience. Stay tuned for updates!

Launching 2026
Schedule a Call
Protein · Stabilizing Suspension · Cosmetic Grade

Epidermal Growth Factor

Recombinant sh-Oligopeptide-1 (EGF)

Recombinant human EGF (sh-Oligopeptide-1) in a stabilizing aqueous suspension for cosmetic renewal serums.*

  • Two strengths: 0.08% standard or 0.8% lab concentrate (10X) · 1 g to 10 g glass vials
  • Stabilizing aqueous suspension · refrigerate 2–8 °C
  • Cosmetic INCI: sh-Oligopeptide-1 only · COA + SDS + TDS per strength
Strength: 0.08% sh-Oligopeptide-1 Full composition
Shipped in a stabilizing aqueous suspension to protect protein integrity and extend shelf life. Refrigerate 2–8 °C; reconstitute/dilute into your finished formula per the formulation guide. See SDS for full composition.
Target pH
5.5 – 7.0
Shelf life (RT · refrigerated)
6–12 mo · 12–24 mo
Cosmetic INCI (finished product)
sh-Oligopeptide-1

Suspension stabilizers in the shipped bulk are processing aids and are not declared on the finished-product INCI when the material is used as directed. See SDS for details.

1
Cold chain
Ship & store 2–8 °C
COA & SDS
Every batch
Cosmetic grade
Recombinant protein
Specifications

Everything you need on the technical data sheet.

INCI Name
sh-Oligopeptide-1
CAS #
62253-63-8
Strengths
0.08% std · 0.8% lc (10X)
Carrier
Aqueous stabilizing suspension
Appearance
Opaque suspension; resuspend before use
pH
5.5 – 7.0
Storage
2–8 °C refrigerated
Shelf Life
6–12 mo RT · 12–24 mo refrigerated
Epidermal Growth Factor illustration sh-Oligopeptide-1 · CAS 62253-63-8 · ~6,045 Da
The protein

sh-Oligopeptide-1: Biomimetic Regeneration for Advanced Skincare

sh-Oligopeptide-1 is a 53-amino acid recombinant peptide designed as a biomimetic analog to human Epidermal Growth Factor (EGF). By binding to the epidermal growth factor receptor (EGFR) on keratinocytes and fibroblasts, it activates key signal transduction pathways, initiating a cellular cascade that stimulates proliferation, accelerates epidermal renewal, and upregulates the synthesis of extracellular matrix components like collagen, elastin, and hyaluronic acid. Within cosmetic science, this peptide is positioned as a high-performance bioactive for premium anti-aging formulations, post-procedure recovery matrices, and targeted scar-reduction serums.

Market context: — While Formulate Labs provides sh-Oligopeptide-1 under its INCI designation, not specific trade-name SKUs, understanding the competitive landscape highlights various approaches to this potent peptide. Competitors market sh-Oligopeptide-1, for example, as plant-derived biomimetic structural boosters (found in Epitensive™-class actives), bacterially fermented peptides optimized for room-temperature stability (found in SpecBio™ EGF Plus-class actives), or nano-encapsulated for enhanced penetration (found in CG-EGF-class actives). Formulate Labs focuses on delivering a rigorously validated, high-purity sh-Oligopeptide-1 raw material for your bespoke cosmetic developments.

Formulate Labs provides sh-Oligopeptide-1 in a targeted stabilizing aqueous suspension, meticulously crafted to ensure optimal stability and bioavailability. Our concentrate simplifies integration into cosmetic formulations, allowing chemists to achieve final product concentrations typically ranging from 1 to 10 ppm for potent, efficacious results.

We ship recombinant EGF in a stabilizing aqueous suspension at two strengths — standard (0.08%) for typical cosmetic dilution workflows, or a 10X lab concentrate (0.8%) when you want maximum loading in minimal volume. The suspension helps protect the active during refrigerated storage and reduce deterioration — see SDS for composition details.*

Suspension
Shelf-life strategy
2–8 °C
Refrigerated storage
10X
Lab concentrate option
0
Added preservative
Ingredient deck assessment

What this material is and isn’t.

Vegan
Recombinant protein, no animal-derived inputs
Non-GMO
Bioengineered / fermentation-derived where applicable
Cruelty-free
No animal testing in our process
Kosher-suitable
Ingredient deck assessed Kosher-suitable
Halal-suitable
Ingredient deck assessed Halal-suitable
Made & Mixed in USA
US synthesis + US factory

These attributes are assessments based on the ingredient deck and the supplier information available to us. They are not third-party certifications. If your finished product requires a specific certified status, please reach out and we’ll walk through what we can document.

Made to Order

Built fresh on our robotic platform.

Every lot is produced to order in our AI-powered robotic factory. Nothing sits on a warehouse shelf going stale - you get a date-of-manufacture-fresh batch every time.

01
Order placed
You pick a size and quantity. We confirm specs against your formulation if you have one.
02
Robotic production
Your inputs go in. We process, blend, and fill sealed packaging - all inside our AI-powered robotic factory.
03
Batch QC + COA
Every batch is tested for actives, pH, micro, and appearance. A batch-specific COA, SDS, and TDS ship with the order.
Why formulators reach for it

Science-backed cosmetic positioning.

Supports a renewed-looking skin finish*
Positioned around keratinocyte renewal and matrix-support signaling in published cosmetic in-vitro and panel work.
Designed for premium serums*
Best-fit for high-end renewal serums, eye treatments, and recovery-positioned cosmetic aftercare (not medical wound treatment).
Cold-chain stabilized*
Stabilizing suspension matrix with refrigerated handling to protect protein integrity and reduce deterioration during storage.
Protein-only cosmetic INCI*
Finished-product INCI lists sh-Oligopeptide-1; suspension stabilizers are disclosed on SDS/TDS but drop from the cosmetic deck when reconstituted per TDS.

Formulate Labs supplies sh-Oligopeptide-1 under its INCI designation for cosmetic raw material use and does not sell branded or trade-name finished products.

Published research

Peer-reviewed literature for due diligence.

Epidermal Growth Factor (sh-Oligopeptide-1) is widely cited in skin-science literature for keratinocyte renewal, EGFR signaling, and cosmetic recovery positioning. These are independent, third-party papers we link for formulators evaluating mechanism, tolerability, and published panel data. We did not conduct this research and do not guarantee replication in your finished formula.

2012
Clinical trial
Journal of Drugs in Dermatology

Improved texture and appearance of human facial skin after daily topical application of barley bioengineered epidermal growth factor

Schouest B, et al.

A three-month study demonstrating that daily topical application of barley-bioengineered EGF serum significantly improves fine lines, pore size, and skin texture.

2016
Clinical trial
Journal of Cosmetic Dermatology

The Effect of a Combination of Recombinant EGF Cosmetic Serum and a Crosslinked HA Serum on Periorbital Wrinkles

Draelos ZD

Combining recombinant EGF with crosslinked hyaluronic acid yields statistically significant enhancements in skin smoothness, firmness, and barrier function.

2023
Review
Journal of Cosmetic Dermatology

Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: a systematic review

Martinez-Carpio PA, et al.

Systematic review stressing that while cosmetic-grade sh-oligopeptide-1 is widely used for anti-aging, rigorous preclinical bioactivity validation remains necessary.

These citations are provided for informational and formulation-research purposes only. Study designs, concentrations, vehicle systems, and populations vary and may not match the suspensions on this page. Published results do not constitute FDA or EU cosmetic claim substantiation for your brand. Always review the primary literature and consult your regulatory counsel before making structure/function statements on finished products.

Composition

What’s in this suspension.

This is the bulk composition as it ships. Updates dynamically when you change the strength above. The active line shows the EGF loading at the selected concentration. Suspension stabilizers in the shipped bulk protect the active during storage and are not declared on the finished-product cosmetic INCI when the protein is reconstituted / diluted into your formula as directed. Full stabilizer identity and concentration are on the SDS.

Suspension stabilizer · 35% sh-Oligopeptide-1 · 0.08% Purified Water · 64.92%
Suspension stabilizer
Salting-out stabilizer (see SDS)
35%
sh-Oligopeptide-1
CAS62253-63-8
Active protein / peptide
0.08%
Purified Water
CAS7732-18-5
Solvent (balance)
64.92%
Formulation guide

Built for chemists who sweat the details.

Typical use rate (std)
0.01–0.1% of suspension into finished formula (protein active ~0.00001–0.0001% in-formula)
Typical use rate (lc)
Dilute 10X first, then use at 0.01–0.1% of working stock
Solubility
Aqueous suspension; dialyze or buffer-exchange to remove suspension stabilizers before certain finished phases (see TDS)
pH compatibility
5.5 – 7.0 (suspension); target finished-formula pH 4.5 – 7.0 per your stability data
Add at
Cool-down phase, ≤ 40 °C after reconstitution / dialyzation
Storage (raw)
Refrigerated 2–8 °C; ship cold; resuspend gently before sampling
Preservation
Unpreserved suspension — finished formula must include appropriate preservation
Pairs well with
Hyaluronic acid, niacinamide, panthenol, copper tripeptide-1, centella, sea kelp bioferment

Documentation

SDS + TDS are issued per strength. Links swap when you change concentration above. COA is batch-specific and ships with the order.

Need something different?
Custom concentrations, bulk sizing, COA-on-file, or a regulatory packet - reach out and we’ll quote.
Compliance & safety

The fine print, in plain English.

What it’s for
Cosmetic raw material - leave-on and rinse-off skincare at the use rates in the formulation guide. Reconstitute / dilute the suspension per TDS before incorporation. Not a finished consumer product.
Claims guidance
Cosmetic structure / function language only. Do not make therapeutic claims (heals wounds, treats burns, regrows skin medically). Downstream finished-product claims must be substantiated by the brand.
Storage
  • Store refrigerated at 2–8 °C in original sealed container.
  • Protect from light; do not freeze.
  • Room-temperature excursions shorten shelf life; see TDS for opened-vial guidance.
Regulatory
  • Finished-product INCI: sh-Oligopeptide-1 (suspension processing aids not declared when used as directed).
  • Full suspension composition, including stabilizer identity, is disclosed on the SDS.
  • Compatible with FDA cosmetic regulations and EU 1223/2009 for the intended use when properly reconstituted.
Handling
Protein suspensions require gentle handling and cold-chain discipline. Reconstitute per TDS; avoid prolonged agitation or heat. Patch-test finished formulations per standard cosmetic protocol.
Questions
Documentation, regulatory, or custom sizing - email materials@formulatelabs.ai.

Statements contained on this page (including any marked with *) have not been evaluated by the U.S. Food and Drug Administration. This product is a cosmetic raw material and is not intended to diagnose, treat, cure, or prevent any disease.

1 g
$420.00
Added to cart View cart →